Recursion Pharmaceuticals Stock Analysis

Recursion Stock Analysis Notes

About 69.0% of the company shares are owned by institutional investors. The book value of Recursion Pharmaceuticals was at this time reported as 1.83. The company recorded a loss per share of 1.57. Recursion Pharmaceuticals had not issued any dividends in recent years. Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Recursion Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 400 people. To find out more about Recursion Pharmaceuticals contact Christopher Gibson at 385 269 0203 or learn more at https://www.recursion.com.

Recursion Pharmaceuticals Investment Alerts

Recursion Pharmaceuticals Upcoming and Recent Events

Recursion Largest EPS Surprises

View All Earnings Estimates

Recursion Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Recursion Stock Institutional Investors

Note, although Recursion Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Recursion Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.51 B.

Recursion Profitablity

Management Efficiency

Recursion Pharmaceuticals has return on total asset (ROA) of (0.364) % which means that it has lost $0.364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7849) %, meaning that it created substantial loss on money invested by shareholders. Recursion Pharmaceuticals' management efficiency ratios could be used to measure how well Recursion Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.55 in 2025. Return On Capital Employed is likely to drop to -0.75 in 2025. At this time, Recursion Pharmaceuticals' Net Tangible Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 260.3 M in 2025, whereas Total Assets are likely to drop slightly above 520.4 M in 2025.

Technical Drivers

As of the 18th of January 2025, Recursion Pharmaceuticals holds the Semi Deviation of 5.13, coefficient of variation of 4518.66, and Risk Adjusted Performance of 0.0271. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Recursion Pharmaceuticals, as well as the relationship between them.

Recursion Pharmaceuticals Price Movement Analysis

Recursion Pharmaceuticals Insider Trading Activities

Recursion Pharmaceuticals Outstanding Bonds

Recursion Pharmaceuticals Predictive Daily Indicators

Recursion Pharmaceuticals Corporate Filings

Recursion Pharmaceuticals Forecast Models

Recursion Pharmaceuticals' time-series forecasting models are one of many Recursion Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Recursion Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Recursion Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Recursion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Recursion Pharmaceuticals. By using and applying Recursion Stock analysis, traders can create a robust methodology for identifying Recursion entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Recursion analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Recursion analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Recursion Pharmaceuticals stock analysis indicators help investors evaluate how Recursion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Recursion Pharmaceuticals shares will generate the highest return on investment. By understating and applying Recursion Pharmaceuticals stock analysis, traders can identify Recursion Pharmaceuticals position entry and exit signals to maximize returns.

When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.